Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
This study determines the risk of DID after modern-technique postoperative XRT.
2
Conclusions: Surgery and postoperative XRT offer relatively good LRC and moderate overall survival rates.
3
This report reviews our institutional experience with modern radical surgery and XRT for this disease.
4
The remaining 37 patients were managed by XRT alone.
5
Consequently, different chemotherapeutic regimens in combination with XRT are being evaluated in the treatment of this disease.
6
Patients and methods: A total of 202 patients were treated with surgery and postoperative XRT for NSCLC.
7
Conclusions: Cancer survivors with prior C- XRT have higher incidence of all-cause mortality and MACE after TAVR.
8
Conclusions: PRS reflect the presence of tumor phenotypes that vary substantially in their clinical behavior and response to XRT.
9
History of palliative XRT was the only predictive factor of inferior PFS and OS after auto-SCT on multivariate analysis.
10
No patient had gross residual disease after surgery; the median XRT dose was 63.7 Gy.
11
The median XRT dose was 55 Gy with fraction size of 1.8 to 2 Gy.
12
Results: Of the 610 patients who underwent TAVR for symptomatic severe aortic stenosis, 75 had prior C-XRT.
13
For patients with rectal recurrence after initial conservative surgery, XRT is an alternative to abdominoperineal resection if major surgical resection is contraindicated.
14
Background: Improved cancer survival in patients treated with thoracic ionizing radiation (XRT) has resulted in unanticipated surge of aortic stenosis.
15
The authors performed a systemic review and meta-analysis of clinical studies for the outcomes after TAVR in cancer survivors with prior C-XRT.
16
Two Group I patients received no radiation therapy (XRT); others received XRT to the primary tumor and to some metastatic sites.